norfloxacin has been researched along with betadex in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| D'Souza, SA; Pandey, S; Ray, J; Udupa, N | 1 |
| Agrawal, A; Dua, K; Garg, V; Himaja, M; Pabreja, K; Ramana, MV; Sara, UV | 1 |
| Ge, XH; Huang, ZB; Li, LS; Li, YP; Liu, X | 1 |
| Chattah, AK; Garnero, C; Longhi, MR; Mroue, KH; Pfund, LY; Ramamoorthy, A | 1 |
| Chiriac, AP; Nistor, MT; Nita, LE; Tartau, L | 1 |
| Loh, GO; Peh, KK; Tan, YT | 1 |
| Adams, AI; Buttchevitz, A; Christ, AP; Mendes, C; Oliveira, PR; Ribas, KG; Silva, MA; Wiemes, BP | 1 |
| Barison, A; Bernardi, LS; Buttchevitz, A; Mendes, C; Ocampos, FM; Oliveira, PR; Silva, MA | 1 |
| Chattah, AK; Chierentin, L; Delvadia, P; Garnero, C; Karnes, T; Longhi, MR; Salgado, HR | 1 |
| Bernardi, LS; Buttchevitz, A; Kruger, JH; Mendes, C; Oliveira, PR; Silva, MA | 1 |
| De Almeida, WB; de Sousa, SM; Guimarães, L; Maia, PP; Nascimento, CS | 1 |
| Andrade, TA; Araújo, AAS; Costa, MDS; Coutinho, HDM; Cruz, RPD; Freitas, TS; Menezes, IRA; Menezes, PDP; Nunes, PS; Oliveira, FS; Pereira, RLS; Quintans-Júnior, LJ; Serafini, MR; Sousa, BMH | 1 |
| Aloisio, C; Chattah, AK; Fabietti, L; Garnero, C; Longhi, M | 1 |
| Aloisio, C; Garnero, C; Gracia-Vásquez, S; Longhi, M; Ponce-Ponte, M; Romero-Guerra, DM | 1 |
| Bongioanni, A; Bueno, MS; Chierentin, L; Garnero, C; Longhi, MR; Nunes Salgado, HR | 1 |
| Bai, H; Fu, X; Liu, L; Lv, F; Peng, K; Qi, R; Wang, S; Zhao, H | 1 |
| Chen, G; Gao, H; Gu, J; Hu, A; Huang, A; Li, L; Li, X; Ma, C; Qiu, X; Shen, J; Wang, Z; Wu, Y; Xu, J; Yang, T; Yang, Z; Zhong, L; Zhu, C | 1 |
17 other study(ies) available for norfloxacin and betadex
| Article | Year |
|---|---|
Absorption of ciprofloxacin and norfloxacin when administered as niosome-encapsulated inclusion complexes.
Topics: Absorption; Administration, Intranasal; Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; beta-Cyclodextrins; Ciprofloxacin; Cyclodextrins; Drug Carriers; Drug Stability; Liposomes; Norfloxacin; Rats; Temperature | 1997 |
Investigation of enhancement of solubility of norfloxacin beta-cyclodextrin in presence of acidic solubilizing additives.
Topics: Anti-Infective Agents; Ascorbic Acid; Bacillus subtilis; beta-Cyclodextrins; Citric Acid; Escherichia coli; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Particle Size; Pseudomonas aeruginosa; Solubility; Spectrophotometry, Infrared; Staphylococcus aureus; Technology, Pharmaceutical; Temperature; Wettability | 2007 |
[Study on the interaction between p-octacarboxyphenylazocalix[8]arene and norfloxacin by fluorescence spectrometry].
Topics: Animals; beta-Cyclodextrins; Calixarenes; Cattle; DNA; Hydrogen-Ion Concentration; Molecular Structure; Norfloxacin; Spectrometry, Fluorescence; Temperature | 2007 |
insights into novel supramolecular complexes of two solid forms of norfloxacin and β-cyclodextrin.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Magnetic Resonance Spectroscopy; Norfloxacin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2013 |
Multilayered structure based on poly(N,N-dimethyl-acrylamide-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane) prepared in a multiphase gelation process.
Topics: Acrylamides; Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Biocompatible Materials; Drug Delivery Systems; Gels; Liver; Norfloxacin; Rats; Rats, Wistar | 2013 |
Effect of HPMC concentration on β-cyclodextrin solubilization of norfloxacin.
Topics: beta-Cyclodextrins; Hypromellose Derivatives; Methylcellulose; Norfloxacin; Solubility; Solvents; Volatilization | 2014 |
Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 1. Preparation, physicochemical and microbiological characterization.
Topics: Anti-Bacterial Agents; beta-Cyclodextrins; Differential Thermal Analysis; Drug Carriers; Drug Stability; Microscopy, Electron, Scanning; Norfloxacin; Pharmaceutical Preparations; Potentiometry; Powder Diffraction; Solubility; Spectroscopy, Fourier Transform Infrared; Staphylococcus epidermidis | 2015 |
Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 2. Inclusion mode and stability studies.
Topics: Anti-Bacterial Agents; beta-Cyclodextrins; Differential Thermal Analysis; Drug Delivery Systems; Drug Resistance, Bacterial; Drug Stability; Microscopy, Electron, Scanning; Norfloxacin; Pharmaceutical Preparations; Potentiometry; Powder Diffraction; Solubility; Spectroscopy, Fourier Transform Infrared; Staphylococcus epidermidis; Technology, Pharmaceutical | 2015 |
Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Drug Compounding; Freeze Drying; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Scanning; Norfloxacin; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2015 |
Quantitative Analysis of Norfloxacin in β-Cyclodextrin Inclusion Complexes--Development and Validation of a Stability-indicating HPLC Method.
Topics: beta-Cyclodextrins; Buffers; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Limit of Detection; Norfloxacin | 2015 |
Computational investigation on the host-guest inclusion process of norfloxacin into β-cyclodextrin.
Topics: beta-Cyclodextrins; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Chemical; Norfloxacin; Thermodynamics | 2016 |
Evaluation of the antibacterial and modulatory potential of α-bisabolol, β-cyclodextrin and α-bisabolol/β-cyclodextrin complex.
Topics: alpha-Cyclodextrins; Anti-Bacterial Agents; beta-Cyclodextrins; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Monocyclic Sesquiterpenes; Norfloxacin; Pseudomonas aeruginosa; Sesquiterpenes; Staphylococcus aureus | 2017 |
Improving the Stability and the Pharmaceutical Properties of Norfloxacin Form C Through Binary Complexes with β-Cyclodextrin.
Topics: Anti-Bacterial Agents; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Drug Delivery Systems; Drug Stability; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Norfloxacin; Sequestering Agents; Solubility; X-Ray Diffraction | 2018 |
Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Freeze Drying; Glutamic Acid; Norfloxacin; Solubility | 2018 |
β-cyclodextrin complexation as an approach to enhance the biopharmaceutical properties of Norfloxacin B Hydrate.
Topics: beta-Cyclodextrins; Drug Carriers; Norfloxacin; Structure-Activity Relationship | 2019 |
Optically-controlled supramolecular self-assembly of an antibiotic for antibacterial regulation.
Topics: Anti-Bacterial Agents; Azo Compounds; Bacteria; beta-Cyclodextrins; Drug Resistance, Bacterial; Isomerism; Norfloxacin; Temperature; Ultraviolet Rays | 2019 |
Sensitive determination of Norfloxacin in milk based on β-cyclodextrin functionalized silver nanoparticles SERS substrate.
Topics: Animals; beta-Cyclodextrins; Humans; Metal Nanoparticles; Milk; Norfloxacin; Silver; Spectrum Analysis, Raman | 2022 |